BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25239732)

  • 1. Variability in mitotic figures in serial sections of thin melanomas.
    Knezevich SR; Barnhill RL; Elder DE; Piepkorn MW; Reisch LM; Pocobelli G; Carney PA; Elmore JG
    J Am Acad Dermatol; 2014 Dec; 71(6):1204-11. PubMed ID: 25239732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
    Saldanha G; Ali R; Bakshi A; Basiouni A; Bishop R; Colloby P; Craig P; Da Forno P; Edward S; Espinosa de Los Monteros O; Evans A; Jamieson L; Rytina E; Bamford M
    Histopathology; 2020 May; 76(6):803-813. PubMed ID: 31879972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic Forms and Classification of Dermal Mitotic Figure Density in Primary Cutaneous Melanoma: A Retrospective Study.
    Marsch AF; McKee RM; Hinds BR
    Am J Dermatopathol; 2020 Jan; 42(1):35-40. PubMed ID: 31884499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.
    Casper DJ; Ross KI; Messina JL; Sondak VK; Bodden CN; McCardle TW; Glass LF
    Am J Dermatopathol; 2010 Oct; 32(7):650-4. PubMed ID: 20559123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
    Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain.
    Ottmann K; Tronnier M; Mitteldorf C
    J Am Acad Dermatol; 2015 Oct; 73(4):637-44. PubMed ID: 26278815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
    Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
    Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
    Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ
    Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.
    Ponti G; Pollio A; Cesinaro AM; Pellacani G; Magnoni C; Seidenari S
    Cancer Epidemiol; 2012 Jun; 36(3):303-5. PubMed ID: 22153914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
    Kirkland EB; Zitelli JA
    Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mitotic rate still useful in the management of patients with thin melanoma?
    Tejera-Vaquerizo A; Pérez-Cabello G; Marínez-Leborans L; Gallego E; Oliver-Martínez V; Martín-Cuevas P; Arias-Santiago S; Aneiros-Fernández J; Herrera-Acosta E; Traves V; Herrera-Ceballos E; Nagore E
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2025-2029. PubMed ID: 28750139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
    Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
    J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.
    Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F
    Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists at one institution.
    Larson AR; Rothschild B; Walls AC; Granter SR; Qureshi AA; Murphy GF; Laga AC
    J Cutan Pathol; 2015 Aug; 42(8):536-41. PubMed ID: 25929156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.